Artículos por temáticas

Refractory Homicidal Ideation in a Young Adult Male With High-Functioning Autism Spectrum Disorder and Schizophrenia

Patel NR, Rehmani N, Utter R, Gracious B.

Cureus. 2024 Jul 26;16(7):e65436. doi: 10.7759/cureus.65436. eCollection 2024 Jul.

Editorial: Pediatric autoimmune neuropsychiatric syndrome

Bottoms N, Rice S, Veerapandiyan A.

Front Behav Neurosci. 2024 Aug 6;18:1467469. doi: 10.3389/fnbeh.2024.1467469. eCollection 2024.

Gamified Closed-Loop Intervention Enhances Tic Suppression in Children: A Randomized Trial

Rotstein MS, Zimmerman-Brenner S, Davidovitch S, Ben-Haim Y, Koryto Y, Sion R, Rubinstein E, Djerassi M, Lubiniaker N, Peleg TP, Steinberg T, Leitner Y, Raz G.

Mov Disord. 2024 Aug;39(8):1310-1322. doi: 10.1002/mds.29875. Epub 2024 Jun 16.

The use of text messages as an alternative invitation method for breast cancer screening: A randomized controlled trial (M-TICS study)

Vives N, Vidal C, de Guzman EN, Farre A, Panera JA, Binefa G, Garcia M; M-TICS research group.

PLoS One. 2024 Aug 29;19(8):e0306720. doi: 10.1371/journal.pone.0306720. eCollection 2024.

Editorial: Reviews in emotional and behavioral dyscontrol in neurological disorders

Tan T, Palumbo S.

Front Behav Neurosci. 2024 Jul 22;18:1447287. doi: 10.3389/fnbeh.2024.1447287. eCollection 2024.

Case Report: Second-order Contrast Sensitivity in Tourette Syndrome

Pinho OC, Costa MFD, Souza GDS.

Turk Psikiyatri Derg. 2024 Summer;35(2):156-161. doi: 10.5080/u26835.

An update on pharmacotherapy for trigeminal neuralgia

Pergolizzi JV Jr, LeQuang JA, El-Tallawy SN, Wagner M, Ahmed RS, Varrassi G.

Expert Rev Neurother. 2024 Aug;24(8):773-786. doi: 10.1080/14737175.2024.2365946. Epub 2024 Jun 13.

Validation and assessment of the self-injurious behavior scale for tic disorders (SIBS-T)

Szejko N, Schlarmann HG, Pisarenko A, Haas M, Brandt V, Jakubovski E, Müller-Vahl KR.

Sci Rep. 2024 Jul 31;14(1):17727. doi: 10.1038/s41598-024-66528-6.

Effectiveness and Acceptability of Targeted Text Message Reminders in Colorectal Cancer Screening: Randomized Controlled Trial (M-TICS Study)

Vives N, Travier N, Farre A, Binefa G, Vidal C, Pérez Lacasta MJ, Ibáñez-Sanz G, Niño de Guzmán EP, Panera JA, Garcia M; M-TICS Research Group.

JMIR Public Health Surveill. 2024 Jul 31;10:e57959. doi: 10.2196/57959.

Addressing co-occurring conditions in behavioural therapy for tic disorders: a review and guideline

Sanderson C, Verdellen C, Debes N, Tárnok Z, van de Griendt J, Zimmerman-Brenner S, Murphy T.

Eur Child Adolesc Psychiatry. 2024 Jul;33(7):2111-2127. doi: 10.1007/s00787-022-02097-1. Epub 2022 Oct 25.

A Novel PDE10A Inhibitor for Tourette Syndrome and Other Movement Disorders

Marshall RD, Menniti FS, Tepper MA.

Cells. 2024 Jul 22;13(14):1230. doi: 10.3390/cells13141230.

Novel drug treatments for pain in advanced cancer and serious illness: a focus on neuropathic pain and chemotherapy-induced peripheral neuropathy

Davis MP.

Palliat Care Soc Pract. 2024 Jul 31;18:26323524241266603. doi: 10.1177/26323524241266603. eCollection 2024.

The effects of Shaoma Zhijing granules and its main components on Tourette syndrome

Zhao Q, Hu Y, Yan Y, Song X, Yu J, Wang W, Zhou S, Su X, Bloch MH, Leckman JF, Chen Y, Sun H.

Phytomedicine. 2024 Jul;129:155686. doi: 10.1016/j.phymed.2024.155686. Epub 2024 Apr 26.

Gilles de la Tourette syndrome as a rare co-morbidity of Klinefelter syndrome

Cavanna AE, Paini G, Purpura G, Riva A, Nacinovich R, Seri S.

Neurol Sci. 2024 Aug;45(8):4033-4035. doi: 10.1007/s10072-024-07573-x. Epub 2024 May 7.

Genome-Wide Association Study Points to Novel Locus for Gilles de la Tourette Syndrome

Tsetsos F, Topaloudi A, Jain P, Yang Z, Yu D, Kolovos P, Tumer Z, Rizzo R, Hartmann A, Depienne C, Worbe Y, Müller-Vahl KR, Cath DC, Boomsma DI, Wolanczyk T, Zekanowski C, Barta C, Nemoda Z, Tarnok Z,

Biol Psychiatry. 2024 Jul 15;96(2):114-124. doi: 10.1016/j.biopsych.2023.01.023. Epub 2023 Feb 2.